Suppr超能文献

在体内将托美汀与透明质酸一起给药可调节术后巨噬细胞条件培养基中的蛋白酶水平。

In vivo administration of tolmetin in hyaluronic acid modulates protease levels in postsurgical macrophage-conditioned media.

作者信息

Rodgers K E, Abe H, Campeau J D, Ellefson D D, Girgis W, diZerega G S

机构信息

Livingston Reproductive Biology Laboratory, Department of Obstetrics and Gynecology, University of Southern California School of Medicine, Los Angeles 90033.

出版信息

J Invest Surg. 1992 Oct-Dec;5(4):285-96. doi: 10.3109/08941939209012446.

Abstract

Tolmetin sodium in a hyaluronic acid carrier (tolmetin-HA) was previously shown to reduce adhesion formation and alter the kinetics and levels of cellular influx into the peritoneal cavity after surgery. In this study, the effect of tolmetin-HA on the level of protease activity in macrophage-conditioned media was determined. The level of collagenase activity in macrophage-conditioned media was suppressed at 12 and 24 h after administration of tolmetin-HA. Alternatively, the peak level of elastase activity measured in macrophage-conditioned media was unchanged after tolmetin-HA treatment, but the kinetics of expression of maximal protease activity was delayed from 12 h in the control surgical rabbits to 24 h in tolmetin-HA-treated rabbits. Elevated plasminogen activator activity was detected in acid-treated conditioned media from the tolmetin-HA-treated rabbits when compared to control levels. However, no alteration in the level of plasminogen activator inhibitor activity was present in conditioned media of macrophages harvested from tolmetin-HA-treated rabbits compared to controls. These data suggest that tolmetin-HA treatment altered the levels of neutral protease activity secreted by postsurgical macrophages and may therefore elevate the fibrinolytic potential of the peritoneal cavity after surgery.

摘要

先前研究表明,透明质酸载体中的托美丁钠(tolmetin-HA)可减少粘连形成,并改变术后细胞流入腹腔的动力学和水平。在本研究中,测定了tolmetin-HA对巨噬细胞条件培养基中蛋白酶活性水平的影响。给予tolmetin-HA后12小时和24小时,巨噬细胞条件培养基中的胶原酶活性水平受到抑制。另外,tolmetin-HA处理后,巨噬细胞条件培养基中测得的弹性蛋白酶活性峰值水平未发生变化,但最大蛋白酶活性的表达动力学从对照手术兔的12小时延迟至tolmetin-HA处理兔的24小时。与对照水平相比,在tolmetin-HA处理兔的酸处理条件培养基中检测到纤溶酶原激活剂活性升高。然而,与对照相比,从tolmetin-HA处理兔收获的巨噬细胞条件培养基中纤溶酶原激活剂抑制剂活性水平没有变化。这些数据表明,tolmetin-HA处理改变了术后巨噬细胞分泌的中性蛋白酶活性水平,因此可能提高术后腹腔的纤溶潜力。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验